Search Results 151-160 of 16397 for infliximab

  1. Adalimumab-fkjp (subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Levoketoconazole; Measles Virus Vaccine, Live; Mercaptopurine; Methotrexate; Mumps Virus Vaccine, Live; Poliovirus ...

  2. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    France only: The participant, historically, failed (ie, had an inadequate response with, lost response to, or was intolerant to) infliximab for treatment of ...

  3. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol. 2003 Jan ...

  4. Ixekizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live ...

  5. https://www.mayoclinic.org/patient_consumer_drug.xml

    ... infliximab-axxq-intravenous-route/description/drg-20476981</loc><lastmod>2025-02-01T00:00:00-06:00</lastmod></url><url><loc>https://www.mayoclinic.org/drugs ...

  6. Alefacept (intramuscular route) - Side effects & uses - Mayo Clinic

    Ergotamine; Fentanyl; Infliximab; Pimozide; Quinidine; Sirolimus; Tacrolimus; Terfenadine; Warfarin. Other Interactions. Certain medicines should not be used at ...

  7. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab; Natalizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  8. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    ... Infliximab 10 mg/kg q4wk > 5mg/ml Adalimumab 40 mg qwk > 7.5mg/ml Certolizumab 400 mg q2wk > 25mg/ml Vedolizumab 300 mg q4wk >15mg/mlUstekinumab 90 mg q4wk ...

  9. Adalimumab-aqvh (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aqvh injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol). Exclusion Criteria: Subjects with ulcerative colitis (UC), collagenous colitis or indeterminate colitis ...